Improving Implementation of Lung Cancer Screening in Diverse Populations II
This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may be a new tool to help improve patient understanding of LCS results and adherence to follow-up recommendations.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Mar 4, 2022 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Washington
- Interventions being studied
- Other: CAQ
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Has undergone LCS or is referred for LCS
- Able to give informed consent
- Cognitive or language limitations (i.e., expressive language limitations, non-English speaking
- Known malignancy other than non-melanoma skin cancer
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Seattle Cancer Care AllianceSeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 4, 2022. Always confirm current availability with the study team.